1.上海中医药大学附属曙光医院老年医学科(上海 201203)
2.上海中医药大学附属曙光医院中医肝病科(上海 201203)
陶丽宇,女,博士研究生,主治医师,主要从事中医药治疗老年疾病研究工作
高月求,主任医师,博士研究生导师; E-mail:gaoyueqiu@hotmail.com
扫 描 看 全 文
陶丽宇,陈晓宏,高月求.首乌藤联合黄芪对刀豆蛋白A诱导的小鼠免疫性肝损伤的影响[J].上海中医药杂志,2022,56(08):107-112.
TAO Liyu,CHEN Xiaohong,GAO Yueqiu.Effect of Polygoni Multiflori Caulis and Astragali Radix on concanavalin A⁃induced immune liver injury in mice[J].Shanghai Journal of Traditional Chinese Medicine,2022,56(08):107-112.
陶丽宇,陈晓宏,高月求.首乌藤联合黄芪对刀豆蛋白A诱导的小鼠免疫性肝损伤的影响[J].上海中医药杂志,2022,56(08):107-112. DOI: 10.16305/j.1007-1334.2022.2106072.
TAO Liyu,CHEN Xiaohong,GAO Yueqiu.Effect of Polygoni Multiflori Caulis and Astragali Radix on concanavalin A⁃induced immune liver injury in mice[J].Shanghai Journal of Traditional Chinese Medicine,2022,56(08):107-112. DOI: 10.16305/j.1007-1334.2022.2106072.
目的,2,观察中药首乌藤联合应用黄芪对刀豆蛋白A(ConA)诱导的免疫性肝损伤模型小鼠的影响。,方法,2,健康ICR小鼠(SPF级)70只,随机分为正常组(等量0.9%NaCl溶液)、模型组(等量0.9%NaCl溶液)、正常+低剂量首乌藤组(首乌藤药液2 g·kg,-1,·d,-1,)、正常+高剂量首乌藤组(首乌藤药液6 g·kg,-1,·d,-1,)、模型+低剂量首乌藤组(首乌藤药液2 g·kg,-1,·d,-1,)、模型+高剂量首乌藤组(首乌藤药液6 g·kg,-1,·d,-1,)及模型+高剂量首乌藤+黄芪组(首乌藤药液2 g·kg,-1,·d,-1,+黄芪药液6 g·kg,-1,·d,-1,),每组10只。各组均每日灌胃1次,连续10 d。末次灌胃后模型组、模型+低剂量首乌藤组、模型+高剂量首乌藤组、模型+高剂量首乌藤+黄芪组予ConA 10 mg·kg,-1,尾静脉注射诱导免疫性肝损伤模型,8 h后处死各组小鼠并取材。采用HE染色法观察肝脏病理变化,生化法检测小鼠肝功能,包括丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、丙二醛(MDA)、单胺氧化酶(MAO)、谷胱甘肽 S-转移酶(GST)、直接胆红素(DBIL)、间接胆红素(IBIL),小鼠血脂包括总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)。,结果,2,与正常组比较,模型组小鼠的肝质量、肝脏指数、ALT、AST、MDA和MAO升高(,P,<,0.05),TG和GST降低(,P,<,0.05),肝脏HE染色显示炎性细胞浸润。与模型组比较,模型+低剂量首乌藤组ALT、AST升高(,P,<,0.05),肝脏HE染色可见炎性细胞浸润增加;模型+高剂量首乌藤组ALT、AST、MAO明显升高(,P,<,0.05),MDA升高(,P,<,0.05),GST降低(,P,<,0.05),肝脏HE染色可见炎性细胞浸润加重并伴有部分肝细胞坏死。与模型+高剂量首乌藤组比较,模型+高剂量首乌藤+黄芪组体质量、肝质量、肝脏指数、ALT、AST、MDA、MAO明显降低(,P,<,0.05),GST明显升高(,P,<,0.05),肝脏HE染色未见明显炎性细胞浸润和肝细胞坏死。,结论,2,首乌藤会进一步破坏免疫性肝损伤小鼠的肝脏功能,联合黄芪则可产生一定的保护作用。
Objective,2,To observe the effect of Polygoni Multiflori Caulis (PMC) and PMC plus Astragali Radix (AR) on concanavalin A (ConA) induced immunological liver injury (ILI) in model mice.,Methods,2,Seventy healthy ICR mice (SPF grade) were randomly divided into normal group, model group, normal group plus high-dose or low-dose PMC, model group plus high-dose or low-dose PMC, model group plus high-dose PMC and AR, with 10 mice in each group. After 10 consecutive days of intragastric administration, ConA with 10 mg·kg,-1, injected intravenously was used to induce the ILI model at the last intragastric administration in all groups except the normal groups. 8 hours later, the mice were sacrificed and samples were collected. The pathological changes of liver were observed by HE staining. Liver function (ALT, AST, MDA, MAO, GST, DBIL, IBIL) and blood lipid (TC, TG, LDL-C) were detected by biochemical method.,Results,2,Compared with the normal group, liver weight, liver index, ALT, AST, MDA and MAO of the model group were increased (,P,<,0.05), while TG and GST were decreased (,P,<,0.05). Liver HE staining showed a large number of infiltrated inflammatory cells in the model group. After PMC given (high or low doses), ALT, AST, MDA and MAO levels were increased significantly (,P,<,0.05), while GST was decreased (,P,<,0.05). Additionally, HE staining showed more inflammatory cell infiltration with partial necrosis of liver cells in the model group plus high-dose PMC. However, ILI mice administrated with combination of high-dose PMC and AR, the liver weight, liver index, ALT, AST, MDA and MAO were decreased (,P,<,0.05), but GST was increased (,P,<,0.05). Liver HE staining also showed less inflammatory cell infiltration and necrocytosis.,Conclusion,2,PMC can further destroy the liver function of ILI mice, while RA can produce certain protective effect.
药物性肝损伤免疫性肝损伤首乌藤黄芪小鼠模型中药研究
drug-induced liver injuryimmunological liver injuryPolygoni Multiflori CaulisAstragali Radixmouse modeltraditional Chinese herbal medicine research
CHALASANI N P, HAYASHI P H, BONKOVSKY H L, et al. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury[J].Am J Gastroenterol, 2014, 109(7): 950-966.
中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南[J]. 临床肝胆病杂志,2015, 31(11): 1752-1769.
中华中医药学会肝胆病分会. 中草药相关性肝损伤临床诊疗指南[J]. 临床肝胆病杂志,2016, 32(5): 835-841.
钱英,王秀娟. 肝病中医治疗合理用药与常用中药肝损伤[M]. 北京:人民卫生出版社,2008: 170-276.
肖小河. 药源性疾病及其风险防控[J]. 药学进展,2018, 42(3): 161-163.
陶丽宇,高月求,韦靖,等. 首乌藤相关药理作用及临床运用的研究进展[J]. 时珍国医国药,2018, 29(10): 2486-2488.
朱梓豪,罗光明,张风波,等. 栀子油对ConA诱导的小鼠急性免疫性肝损伤的保护作用[J]. 中国油脂,2019, 44(2): 99-103.
黄继汉,黄晓晖,陈志扬,等. 药理试验中动物间和动物与人体间的等效剂量换算[J]. 中国临床药理学与治疗学,2004, 9(9): 1069-1072.
马晓,杨坤,杜杰,等. 202例药物性肝损伤临床特征回顾性分析[J]. 药物流行病学杂志,2021, 30(1): 23-28.
王伽伯,李春雨,朱云,等. 基于整合证据链的中草药肝毒性客观辨识与合理用药:以何首乌为例[J]. 科学通报,2016, 61(9): 971-980.
LI C, RAO T, CHEN X, et al. HLA-B*35:01 Allele is a potential biomarker for predicting polygonum multiflorum-induced liver injury in humans[J]. Hepatology, 2019, 70(1): 346-357.
国家药典委员会. 中华人民共和国药典(2020年版):一部[S]. 北京:中国医药科技出版社,2020.
李红品,朱虹宇,高兴,等. 基于特异质大鼠胆红素相关转运体功能抑制探讨首乌藤肝损伤机制[J]. 中国中药杂志,2017, 42(18): 3591-3595.
任艳青,李葆林,田宇柔,等. 栀子、连翘等中药配方颗粒体外肝细胞毒性研究[J]. 河北中医药学报,2017, 32(1): 43-46.
陶丽宇,高月求. 患者口服首乌藤与肝损伤风险发生相关性研究[J]. 中西医结合肝病杂志,2021, 31(3): 200-202.
王婉茹,洪滨,单国顺. 何首乌肝毒性作用机制的研究进展[J]. 现代药物与临床,2020, 35(2): 378-382.
王竟静,农汝楠,覃乐,等. 基于网络药理学的黄芪抗肝损伤作用机制研究[J]. 中国药师,2020, 23(6): 1022-1028.
0
浏览量
410
下载量
0
CSCD
0
CNKI被引量
关联资源
相关文章
相关作者
相关机构